The report focuses on the Bicalutamide market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Bicalutamide market. Major Players in the Bicalutamide market are: Sorres Pharma Zhejiang Haizheng Pharmaceutical AstraZeneca ANI Pharmaceuticals Zeneca GmbH Apotex Corporation CORDEN PHARMA GMBH Actavis Pharma Shanghai Fudan Fuhua Pharmaceutical Shanxi Zhendong Pharmaceutical Accel Pharma Sivem Pharmaceuticals Fresenius Kabi Shanghai Zhaohui Pharmaceutical On the basis of types, the Bicalutamide market is primarily split into: Tablets Capsule On the basis of applications, the market covers: Single Drug For Prostate Cancer Combined Chemotherapy For Prostate Cancer Combined Radiation Therapy Or Castration For Prostate Cancer Major Regions or countries covered in this report: United States Europe China Japan India Southeast Asia Latin America Middle East and Africa Others Years considered for this report: Historical Years: 2017-2021 Base Year: 2021 Estimated Year: 2022 Forecast Period: 2022-2029
Table of Content 1 Bicalutamide Market Overview 1.1 Product Overview and Scope of Bicalutamide Market 1.2 Bicalutamide Market Segment by Type 1.2.1 Global Bicalutamide Market Sales and CAGR (%) Comparison by Type (2017-2029) 1.3 Global Bicalutamide Market Segment by Application 1.3.1 Bicalutamide Market Consumption (Sales) Comparison by Application (2017-2029) 1.4 Global Bicalutamide Market, Regi
